BREAKOUT STOCK ALERT UPDATE
OPK - Opko Health, Inc. - Common Stock
Initial Alert Price: $4.21
Price High: $5.01
% Gains/Losses: 19%
(-35% Less Than Expected)
Potential Stop Loss: $4.76
OPK hit $5.01 on Dec. 2nd and we have left the alert open as we continue to monitor the stock. The stock is showing consolidating from the $5.01 breakout and found support at the $4.43 Price Levels and just completed an EMA Crossover from that point. We're currently seeing momentum for the price to retest $5.01 and if it does, then we expect the stock to retest the $6.24-$6.47 Price Levels once again, since it's highest breakout this year on July 21st. #Breakout #Stocks #Trading #Investing #Alerts #StockMarket #Daily #News #Today
Follow for more trade alerts and information & egister your account for Instant Alerts by clicking the link in our signature.
Initial Alert Price: $4.21
Price High: $5.01
% Gains/Losses: 19%
(-35% Less Than Expected)
Potential Stop Loss: $4.76
OPK hit $5.01 on Dec. 2nd and we have left the alert open as we continue to monitor the stock. The stock is showing consolidating from the $5.01 breakout and found support at the $4.43 Price Levels and just completed an EMA Crossover from that point. We're currently seeing momentum for the price to retest $5.01 and if it does, then we expect the stock to retest the $6.24-$6.47 Price Levels once again, since it's highest breakout this year on July 21st. #Breakout #Stocks #Trading #Investing #Alerts #StockMarket #Daily #News #Today
Follow for more trade alerts and information & egister your account for Instant Alerts by clicking the link in our signature.
Related publications
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
Related publications
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.